Neuroscreen
Stealth ModeNeuroscreen develops AI-powered tools for early detection and monitoring of neurodegenerative diseases.
About
Neuroscreen leverages artificial intelligence to create innovative solutions for the early diagnosis and continuous monitoring of neurodegenerative conditions. Their technology aims to provide clinicians with advanced tools to identify disease progression and enable timely interventions, ultimately improving patient outcomes.
Technology stack
detected 2026-06-17Est. monthly stack spend~$70/mo
Email
Google Workspace
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Neuroscreen do?
Neuroscreen leverages artificial intelligence to create innovative solutions for the early diagnosis and continuous monitoring of neurodegenerative conditions. Their technology aims to provide clinicians with advanced tools to identify disease progression and enable timely interventions, ultimately improving patient outcomes.
Where is Neuroscreen headquartered?
Neuroscreen is headquartered in Grays, England.
When was Neuroscreen founded?
Neuroscreen was founded in 2026.
What industry does Neuroscreen operate in?
Neuroscreen operates in MedTech, HealthTech, Neurotech, AI Drug Discovery, Clinical Trials, Biotech.